Pulse Biosciences appoints Kevin Danahy as CEO; grants 450,000 share option

PULSE BIOSCIENCES, INC.

Kevin Danahy, previously Chief Commercial Officer, named CEO effective September 20, 2022.
Annual base salary of $400,000 and target bonus up to 100% of base salary.
Received option to acquire 450,000 shares vesting over 4 years at closing price on grant date.
Amended employment agreement includes 24-month severance if terminated within 2 years.
Danahy brings 20+ years medtech experience from Intuitive Surgical, Zimmer Biomet, Medtronic.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Kevin Danahy

Chief Executive Officer

PLSE · PULSE BIOSCIENCES, INC.

Effective: 2022-09-20
Filed: September 28, 2022, 7:59 PM ET

On September 23, 2022, in connection with the appointment of Kevin Danahy as Chief Executive Officer of Pulse Biosciences, Inc. (the “Company”), Mr. Danahy and the Company entered into an amendment (the “Danahy Amendment”) to Mr. Danahy’s employment agreement, dated February 9, 2022, which was initially entered into in connection with his appointment as Chief Commercial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kevin Danahy was appointed as Chief Executive Officer at PULSE BIOSCIENCES, INC..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

On September 23, 2022, in connection with the appointment of Kevin Danahy as Chief Executive Officer of Pulse Biosciences, Inc. (the “Company”), Mr. Danahy and the Company entered into an amendment (the “Danahy Amendment”) to Mr. Danahy’s employment agreement, dated February 9, 2022, which was initially entered into in connection with his appointment as Chief Commercial Officer.

View on SEC.gov

PULSE BIOSCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0001387131-22-010041

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.